Key Highlights from CNBC’s Stock Discussions
Recently on CNBC's Halftime Report, prominent investment figures discussed the latest movements in the stock market, notably focusing on some major corporations including Cisco Systems, ServiceNow, Regeneron Pharmaceuticals, and Truist Financial Corporation.
Cisco Systems: A Resilient Performer
Jim Lebenthal, a partner at Cerity Partners, kicked off the discussion by highlighting Cisco Systems, Inc. (NASDAQ: CSCO). After reporting impressive earnings two weeks ago, Cisco experienced a minor setback with some profit-taking. However, it appears to be recovering quickly, inching closer to its 52-week high.
Recently, Cisco announced that its fiscal fourth-quarter revenue reached $14.67 billion, surpassing the anticipated $14.62 billion. This notable achievement was accompanied by adjusted earnings of 99 cents per share, which were also above the expected 97 cents per share.
ServiceNow: Embracing AI Innovations
Jason Snipe, founder and CIO of Odyssey Capital Advisors, expressed a favorable outlook on ServiceNow, Inc. (NYSE: NOW). He noted that the company's advancements in artificial intelligence are positively impacting average selling prices. With a revenue of approximately $3.22 billion for the second quarter, ServiceNow outperformed the consensus estimate of $3.12 billion. Its adjusted earnings of $4.09 per share also exceeded the analyst expectations of $3.57 per share.
Regeneron Pharmaceuticals: Facing Challenges
Amy Raskin, Chief Investment Officer at Chevy Chase Trust, shared insights on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Despite facing significant price reductions due to concerns surrounding its Eylea product, the company remains steadfast. On August 26, Regeneron released critical data from the Phase 3 NIMBLE trial, which assessed the investigational cemdisiran monotherapy targeting adults with generalized myasthenia gravis.
Truist Financial: Navigating Stock Trends
Investment strategist Stephanie Link discussed Truist Financial Corporation (NYSE: TFC) as her highlighted trade. With recent insights from Wells Fargo analyst Mike Mayo indicating a downgrade in Truist's rating from Overweight to Equal-Weight, the firm has set a price target of $47. Despite these concerns, Truist gained 0.1% to close at $46.82.
Market Movements: Price Actions
Here's a brief overview of how these stocks performed recently:
- Cisco saw a minor decline of 0.5%, settling at $69.09.
- ServiceNow shares decreased by 1.2% to $917.46.
- Regeneron Pharmaceuticals managed a slight increase of 0.2%, closing at $580.70.
- Truist Financial’s shares closed at $46.82, marking a slight gain of 0.1%.
Investors and analysts alike will continue to monitor these companies as they navigate the evolving market landscape. With advancements in technology and recent earnings reports, these stocks remain focal points for many in the financial community.
Frequently Asked Questions
What stock did Jim Lebenthal recommend?
Jim Lebenthal recommended Cisco Systems (CSCO) based on its performance after earnings reports and recovery towards the 52-week high.
What are ServiceNow's recent earnings results?
ServiceNow reported second-quarter earnings of approximately $3.22 billion, exceeding expectations with adjusted earnings of $4.09 per share.
What challenges is Regeneron facing?
Regeneron is facing pricing pressures due to concerns surrounding its Eylea product, which significantly affected its stock price.
What did Stephanie Link say about Truist Financial?
Stephanie Link mentioned Truist Financial as a notable trade, despite a recent downgrade by an analyst.
What were the latest price movements for the stocks discussed?
Cisco fell 0.5%; ServiceNow dropped 1.2%; Regeneron rose 0.2%; and Truist Financial gained 0.1%.
